2-240757423-ATCCTCCTCCTCCTCCTCC-ATCCTCCTCCTCC
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP3BP6BS1BS2
The NM_001244008.2(KIF1A):c.2748_2753delGGAGGA(p.Glu916_Glu917del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.0171 in 1,355,642 control chromosomes in the GnomAD database, including 153 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.015 ( 17 hom., cov: 0)
Exomes 𝑓: 0.017 ( 136 hom. )
Consequence
KIF1A
NM_001244008.2 disruptive_inframe_deletion
NM_001244008.2 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.36
Genes affected
KIF1A (HGNC:888): (kinesin family member 1A) The protein encoded by this gene is a member of the kinesin family and functions as an anterograde motor protein that transports membranous organelles along axonal microtubules. Mutations at this locus have been associated with spastic paraplegia-30 and hereditary sensory neuropathy IIC. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Apr 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP3
Nonframeshift variant in repetitive region in NM_001244008.2
BP6
Variant 2-240757423-ATCCTCC-A is Benign according to our data. Variant chr2-240757423-ATCCTCC-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 211282.We mark this variant Likely_benign, oryginal submissions are: {Benign=6, Uncertain_significance=1}. Variant chr2-240757423-ATCCTCC-A is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0147 (2022/137566) while in subpopulation AFR AF= 0.0181 (690/38226). AF 95% confidence interval is 0.0169. There are 17 homozygotes in gnomad4. There are 941 alleles in male gnomad4 subpopulation. Median coverage is 0. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 17 AD,AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0147 AC: 2021AN: 137486Hom.: 18 Cov.: 0
GnomAD3 genomes
AF:
AC:
2021
AN:
137486
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0187 AC: 2065AN: 110140Hom.: 11 AF XY: 0.0190 AC XY: 1132AN XY: 59702
GnomAD3 exomes
AF:
AC:
2065
AN:
110140
Hom.:
AF XY:
AC XY:
1132
AN XY:
59702
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0173 AC: 21099AN: 1218076Hom.: 136 AF XY: 0.0171 AC XY: 10284AN XY: 600892
GnomAD4 exome
AF:
AC:
21099
AN:
1218076
Hom.:
AF XY:
AC XY:
10284
AN XY:
600892
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0147 AC: 2022AN: 137566Hom.: 17 Cov.: 0 AF XY: 0.0141 AC XY: 941AN XY: 66620
GnomAD4 genome
AF:
AC:
2022
AN:
137566
Hom.:
Cov.:
0
AF XY:
AC XY:
941
AN XY:
66620
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not specified Uncertain:1Benign:2
Jun 27, 2014
Genetic Services Laboratory, University of Chicago
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Dec 29, 2023
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
May 04, 2022
Mendelics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
not provided Benign:3
Oct 11, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Jul 22, 2016
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
KIF1A: BS1, BS2 -
Intellectual disability, autosomal dominant 9 Benign:1
Dec 17, 2024
Genomic Medicine Center of Excellence, King Faisal Specialist Hospital and Research Centre
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at